York Bridge Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History

York Bridge Wealth Partners, LLC

$394 Million
Q4 2022

A detailed history of York Bridge Wealth Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, York Bridge Wealth Partners, LLC holds 774 shares of VRTX stock, worth $315,931. This represents 0.06% of its overall portfolio holdings.

Number of Shares

774

Previous 776 0.26%

Holding current value

$315,931

Previous $225,000 0.89%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$285.76 - $321.48 $571 - $642	-2 Reduced 0.26%	774 $0
Q3 2022 Oct 18, 2022	SELL	$273.83 - $305.53 $547 - $611	-2 Reduced 0.26%	776 $225,000
Q2 2022 Jul 15, 2022	SELL	$234.96 - $292.55 $1,409 - $1,755	-6 Reduced 0.77%	778 $219,000
Q1 2022 Apr 15, 2022	BUY	$221.42 - $260.97 $173,593 - $204,600	784 New	784 $205,000
Q3 2021 Oct 22, 2021	SELL	$181.39 - $202.99 $185,561 - $207,658	-1,023 Closed	0 $0
Q2 2021 Jul 22, 2021	BUY	$187.49 - $221.1 $5,062 - $5,969	27 Added 2.71%	1,023 $206,000
Q1 2021 Apr 15, 2021	BUY	$207.02 - $241.31 $8,073 - $9,411	39 Added 4.08%	996 $214,000
Q4 2020 Jan 19, 2021	SELL	$207.01 - $276.09 $9,522 - $12,700	-46 Reduced 4.59%	957 $226,000
Q3 2020 Oct 19, 2020	BUY	$255.65 - $303.1 $4,090 - $4,849	16 Added 1.62%	1,003 $273,000
Q2 2020 Jul 20, 2020	SELL	$225.48 - $295.8 $1,578 - $2,070	-7 Reduced 0.7%	987 $287,000
Q1 2020 Apr 16, 2020	SELL	$199.77 - $247.81 $36,957 - $45,844	-185 Reduced 15.69%	994 $237,000
Q4 2019 Jan 17, 2020	SELL	$166.71 - $223.91 $6,001 - $8,060	-36 Reduced 2.96%	1,179 $258,000
Q3 2019 Oct 21, 2019	SELL	$166.23 - $187.09 $10,472 - $11,786	-63 Reduced 4.93%	1,215 $206,000
Q2 2019 Jul 18, 2019	BUY	$164.61 - $190.37 $8,395 - $9,708	51 Added 4.16%	1,278 $234,000
Q1 2019 May 09, 2019	SELL	$163.73 - $194.7 $982 - $1,168	-6 Reduced 0.49%	1,227 $226,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $7,595 - $9,610	50 Added 4.23%	1,233 $204,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $8,386 - $9,637	50 Added 4.41%	1,183 $227,000
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $19,235 - $22,434	132 Added 13.19%	1,133 $193,000
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $4,093 - $4,782	-27 Reduced 2.63%	1,001 $162,000
Q4 2017 Feb 12, 2018	SELL	$137.28 - $155.55 $31,986 - $36,243	-233 Reduced 18.48%	1,028 $159,000
Q3 2017 Oct 27, 2017	SELL	$148.13 - $162.24 $22,219 - $24,336	-150 Reduced 10.63%	1,261 $192,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,411	1,411 $181,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.

Account

York Bridge Wealth Partners, LLC Vertex Pharmaceuticals Inc Transaction History